Corpus Intelligence IC Memo — BEHAVORIAL HEALTH CENTERS 2026-04-26 08:50 UTC
IC Memo — BEHAVORIAL HEALTH CENTERS
Investment Committee Memorandum | TN | 16 beds | Grade D | EBITDA uplift $349K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEHAVORIAL HEALTH CENTERS

CCN 444021 | MAURY, TN | 16 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BEHAVORIAL HEALTH CENTERS is a 16-bed community hospital in MAURY, TN with $4.6M in net patient revenue and a -0.9% operating margin. The hospital serves a payer mix of 58.2% Medicare, 0.0% Medicaid, and 41.8% commercial.

Thesis: Turnaround. Our ML models identify $349K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.9% to 6.7% (+763bps).

Net Revenue HCRIS$4.6M
Current EBITDA COMPUTED$-41K
Operating Margin COMPUTED-0.9%
Occupancy HCRIS86.2%
Revenue / Bed COMPUTED$285K
Net-to-Gross HCRIS88.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
35
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -0.9% places it below the state median. Among 35 size-comparable peers (8-32 beds), the median margin is -0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEHAVORIAL HEALTH CENTERS (Target)TN16$4.6M-0.9%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
TRUSTPOINT HOSPITALTN18$50.8M-0.8%
VANDERBILT BEDFORD COUNTY HOSPTN24$49.5M1.9%
NEWPORT MEDICAL CENTERTN32$47.8M11.6%
FORT LOUDOUN MEDICAL CENTERTN30$41.3M10.0%
CLAIBORNE MEDICAL CENTERTN26$30.9M-9.9%
MARSHALL MEDICAL CENTERTN25$29.5M-28.0%
DELTA MEDICAL CENTER MEMPHISTN10$28.4M3.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $349K (763bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$96K+211bp12mo
Net Collection Rate93.5%97.0%$96K+210bp18mo
Cost to Collect4.5%2.5%$91K+200bp12mo
A/R Days Reduction5200.0%3800.0%$56K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+21bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$96K
Net Collection Rate
$96K
Cost to Collect
$91K
A/R Days Reduction
$56K
Clean Claim Rate
$10K
Total EBITDA Uplift$349K
Current EBITDA$-41K
+ RCM Uplift+$349K
Pro Forma EBITDA$307K
Current Margin-0.9%
Pro Forma Margin6.7%
WC Released (1x)$175K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-64K$3.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-64K$3.5M0.00x-100.0%
Bull Case9.0x11.0x$-57K$4.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-57K$5.0M0.00x-100.0%
Bear Case11.0x10.0x$-70K$1.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-70K$1.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 58.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 8-32 beds
  • Same-state prioritization (n=37)
  • Comp margins: P25=-16.7% / P50=-0.8% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.